Page last updated: 2024-11-02

oxatomide and Disease, Pulmonary

oxatomide has been researched along with Disease, Pulmonary in 1 studies

oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.

Research Excerpts

ExcerptRelevanceReference
" Following the administration of oxatomide 1 mg/kg, the peak plasma concentration (Cmax), the elimination half-life (t1/2), the volume of distribution (Vd), and the area under the curve (AUC) 0-36 h were measured and the following results were obtained: 42."2.70Pharmacokinetics of oxatomide in preterm infants. ( Bertini, G; Ciuffi, M; Dani, C; Filippi, L; Martelli, E; Mazzetti, L; Pezzati, M; Rubaltelli, FF; Zilletti, L, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dani, C1
Martelli, E1
Bertini, G1
Filippi, L1
Pezzati, M1
Mazzetti, L1
Ciuffi, M1
Zilletti, L1
Rubaltelli, FF1

Trials

1 trial available for oxatomide and Disease, Pulmonary

ArticleYear
Pharmacokinetics of oxatomide in preterm infants.
    Drugs under experimental and clinical research, 2002, Volume: 28, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chronic Disease; Half-Life; Histamine H1

2002